Natalia Neparidze, MD, Yale School of Medicine, New Haven, CT, briefly discusses a study assessing the racial differences in treatment and survival among older patients with multiple myeloma (MM). This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.